The Challenge 

Sepsis is a form of acute inflammation; severe cases result in permanent damage to organs or even death. With sepsis the body's response to an infection is too severe which damages the body itself. Every year, sepsis causes the death of 11 million people worldwide and affects many more. Sepsis is treatable with antibiotics, but it is hard to diagnose early on. Every hour that treatment is given earlier impacts the survival chances of patients. The early diagnosis is hard because symptoms of sepsis are not specific and can vary a lot person to person.

The Solution

T.E.S.T. 2022 is going to develop a rapid and easy-to-use biosensor that can detect and quantify biomarkers for sepsis from a blood sample. The biosensor will a multiplex assay in which multiple markers will be included to give a more reliable and insightful diagnosis. Our aim is to produce a test that can give a result within 5 minutes. This result will be a concentration of each biomarker and a class which indicates the severity of the measured concentrations. This test will aid in early detection making early treatment more achievable.

The Mission

By developing a rapid and easy-to-use biosensor, T.E.S.T. 2022 strives to reduce the deaths and suffering caused by sepsis. A disease which is very treatable in early stages. By aiding in early detection early treatment will prevent a lot of the suffering this disease now causes.

This project is being coached by